Neuraseq amyloid radiotracer acquisition for the baltimore longitudinal study of aging (BLSA)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00082
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $93,000 obligated
Award facts
- Opportunity
-
- Amyloid radiotracers for Baltimore Longitudinal Study of Aging Solicitation · 75N98026Q01057 · Posted Aug 26, 2026
- Combined order value
- $93,000 Current and potential, with all options
- Last date to order 3% complete
- IDV ceiling 8% used
- $1,211,250.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Aging awarded a single-award indefinite-delivery contract to Progenics Pharmaceuticals Inc. with a ceiling of $1,211,250 on September 22, 2026, to supply NeuraSeq amyloid radiotracers for the Baltimore Longitudinal Study of Aging (BLSA). The contract is not set-aside and carries a completion date of September 21, 2031.
Place of performance is the United States. The originating solicitation, issued as a non-competitive, sole-source request for quotation under FAR Part 13 and FAR Part 12, called for the supply of 62 amyloid radiotracers with scientific continuity as the justification for sole-source procurement. The solicitation (75N98026Q01057) was posted August 26, 2026, with a response deadline of August 31, 2026. NAICS code 325414 (Biological Product Manufacturing) and PSC code 6505 (Drugs and Biologicals) apply to the procurement.
Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc. and operates from North Billerica, Massachusetts (primary manufacturing and distribution) and Bedford, Massachusetts. The contract carries firm fixed-price terms.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Neuraseq amyloid radiotracers for the baltimore longitudinal study of aging | Office of Logisitics and Acquisition Operations (NIH) | $93,000 |
Quick answers
Who was awarded contract 75N98026D00082?
75N98026D00082 was awarded to Progenics Pharmaceuticals Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 22, 2026.
How much is contract 75N98026D00082 worth?
Orders under 75N98026D00082 have obligated $93,000. 75N98026D00082's own ceiling is $1,211,250.
How many orders have been placed under contract 75N98026D00082?
1 order has been placed under 75N98026D00082, the latest on September 22, 2026.
Which agency awarded contract 75N98026D00082?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00082, with funding from National Institute on Aging (National Institutes of Health).
Who can order from contract 75N98026D00082?
75N98026D00082 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00082 competed?
The extent of competition for 75N98026D00082 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV